相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
J. Cassidy et al.
BRITISH JOURNAL OF CANCER (2011)
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability
Francis Levi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin-5-Fluorouracil-Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963)
Pasquale F. Innominato et al.
CHRONOBIOLOGY INTERNATIONAL (2011)
Androgens Modulate Structure and Function of the Suprachiasmatic Nucleus Brain Clock
Ilia N. Karatsoreos et al.
ENDOCRINOLOGY (2011)
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Timothy S. Maughan et al.
LANCET (2011)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing
Xiao-Mei Li et al.
CANCER RESEARCH (2010)
When Separate Is More Equal
Nancy E. Adler
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Sex Differences in Phase Angle of Entrainment and Melatonin Amplitude in Humans
Sean W. Cain et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Regulation of circadian rhythms and hypothalamic-pituitary-adrenal axis: an overlooked interaction in cancer
Pasquale F. Innominato et al.
LANCET ONCOLOGY (2010)
Clocks not winding down: unravelling circadian networks
Eric E. Zhang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer
Pasquale F. Innominato et al.
CANCER RESEARCH (2009)
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Kohei Shitara et al.
EUROPEAN JOURNAL OF CANCER (2009)
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Rene Adam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Gender-related survival differences associated with EGFR Polymorphisms in metastatic colon cancer
Oliver A. Press et al.
CANCER RESEARCH (2008)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: A prospective clinical trial by the German 5-FU toxicity study group
Matthias Schwab et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
Francis Levi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Circadian rhythms: Mechanisms and therapeutic implications
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Differences in toxicity between men and women treated with 5-fluorouracil therapy for colorectal carcinoma
K Chansky et al.
CANCER (2005)
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer
T Rich et al.
CLINICAL CANCER RESEARCH (2005)
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01
RE Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
H Elsaleh et al.
LANCET (2000)
分享论文
